Anteris Technologies
Christopher Meduri is currently the Chief Medical Officer at Anteris Technologies. Previously, Christopher held positions as an Interventional Cardiologist at Karolinska University Hospital and Piedmont Atlanta Hospital. Christopher completed their fellowship at Beth Israel Deaconess Medical Center and received their Doctor of Medicine from The University of Tennessee Health Science Center. Additionally, Christopher holds a Master of Public Health from Harvard T.H. Chan School of Public Health.
This person is not in any offices
Anteris Technologies
1 followers
Anteris Technologies is a structural heart company focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. Our DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime. DurAVR™ THV is a unique, single-piece valve and its first-in-class biomimetic design replicates the normal blood flow of a healthy human aortic valve. | $AVR | ASX: AVR | #DurAVR #ADAPT #structuralheart #TAVR #TAVI #cardiology